Literature DB >> 14654648

Chromosome 22q11 deletion in patients with ventricular septal defect: frequency and associated cardiovascular anomalies.

Doff B McElhinney1, Deborah A Driscoll, Elissa R Levin, Abbas F Jawad, Beverly S Emanuel, Elizabeth Goldmuntz.   

Abstract

BACKGROUND: A ventricular septal defect (VSD) is the most common form of congenital heart disease and is one of the most common cardiovascular anomalies in individuals with chromosome 22q11 deletion syndrome. However, the frequency of a chromosome 22q11 deletion in patients with a VSD is not known. In addition, among patients with a VSD, it is not clear whether particular types of VSD or associated cardiovascular phenotypic features are associated with a chromosome 22q11 deletion.
METHODS: We prospectively enrolled 125 patients with a conoventricular (n = 100), posterior malalignment (n = 14), or conoseptal hypoplasia (n = 11) VSD who were admitted to Children's Hospital of Philadelphia between November 1991 and December 2001. Patients were studied for a chromosome 22q11 deletion by using fluorescence in situ hybridization.
RESULTS: A chromosome 22q11 deletion was detected in 12 (10%) of the 125 patients. Anatomic features that were significantly associated with a chromosome 22q11 deletion included abnormal aortic arch sidedness, an abnormal aortic arch branching pattern, a cervical aortic arch, and discontinuous pulmonary arteries. There was no correlation between the type of VSD and chromosome 22q11 deletion. Of 20 patients with an abnormal aortic arch and/or discontinuous pulmonary arteries, 45% had a chromosome 22q11 deletion compared with only 3% of those with a left aortic arch, normal aortic arch branching pattern, and continuous branch pulmonary arteries
CONCLUSIONS: A chromosome 22q11 deletion is common in individuals with a conoventricular, posterior malalignment, or conoseptal hypoplasia VSD and anomalies of the aortic arch or branch pulmonary arteries. On the basis of these findings, at a minimum, we recommend testing for a chromosome 22q11 deletion in patients with these types of VSD who have abnormalities of aortic arch sidedness or branching, a cervical aortic arch, and/or discontinuous pulmonary arteries. Testing of patients with these types of VSD but a normal aortic arch and pulmonary arteries may be performed routinely or guided by the presence of associated noncardiovascular features of chromosome 22q11 deletion syndrome.

Entities:  

Mesh:

Year:  2003        PMID: 14654648     DOI: 10.1542/peds.112.6.e472

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

1.  Prenatal Aneuploidies Computerized Screening (SCA TEST): a pilot study on 1000 women.

Authors:  Alessandro Sacco; Claudio Coco; Lucia Mangiafico; Pietro Cignini; Alessandra Tiezzi; Claudio Giorlandino
Journal:  J Prenat Med       Date:  2007-10

Review 2.  CHD associated with syndromic diagnoses: peri-operative risk factors and early outcomes.

Authors:  Benjamin J Landis; David S Cooper; Robert B Hinton
Journal:  Cardiol Young       Date:  2015-09-08       Impact factor: 1.093

Review 3.  Transcription factor pathways and congenital heart disease.

Authors:  David J McCulley; Brian L Black
Journal:  Curr Top Dev Biol       Date:  2012       Impact factor: 4.897

Review 4.  Congenital heart diseases and cardiovascular abnormalities in 22q11.2 deletion syndrome: From well-established knowledge to new frontiers.

Authors:  Marta Unolt; Paolo Versacci; Silvia Anaclerio; Caterina Lambiase; Giulio Calcagni; Matteo Trezzi; Adriano Carotti; Terrence Blaine Crowley; Elaine H Zackai; Elizabeth Goldmuntz; James William Gaynor; Maria Cristina Digilio; Donna M McDonald-McGinn; Bruno Marino
Journal:  Am J Med Genet A       Date:  2018-04-16       Impact factor: 2.802

5.  NAT1, NOS3, and TYMS genotypes and the risk of conotruncal cardiac defects.

Authors:  Philip J Lupo; Laura E Mitchell; Elizabeth Goldmuntz
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-12-01

6.  Genome-Wide Association Studies and Meta-Analyses for Congenital Heart Defects.

Authors:  A J Agopian; Elizabeth Goldmuntz; Hakon Hakonarson; Anshuman Sewda; Deanne Taylor; Laura E Mitchell
Journal:  Circ Cardiovasc Genet       Date:  2017-06

Review 7.  Molecular regulation of cardiomyocyte differentiation.

Authors:  Sharon L Paige; Karolina Plonowska; Adele Xu; Sean M Wu
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

8.  Presenting phenotype in 100 children with the 22q11 deletion syndrome.

Authors:  Sólveig Oskarsdóttir; Christina Persson; Bengt O Eriksson; Anders Fasth
Journal:  Eur J Pediatr       Date:  2004-11-23       Impact factor: 3.183

9.  Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.

Authors:  Fabíola P Monteiro; Társis P Vieira; Ilária C Sgardioli; Miriam C Molck; Ana Paula Damiano; Josiane Souza; Isabella L Monlleó; Marshall I B Fontes; Agnes C Fett-Conte; Têmis M Félix; Gabriela F Leal; Erlane M Ribeiro; Claudio E M Banzato; Clarissa de R Dantas; Iscia Lopes-Cendes; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

10.  22q11.2 deletions in patients with conotruncal defects: data from 1,610 consecutive cases.

Authors:  Shabnam Peyvandi; Philip J Lupo; Jennifer Garbarini; Stacy Woyciechowski; Sharon Edman; Beverly S Emanuel; Laura E Mitchell; Elizabeth Goldmuntz
Journal:  Pediatr Cardiol       Date:  2013-04-21       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.